Related Experiment Videos

Anti-allergic properties of a new coumarin compound (BM 15,100) [proceedings]

A Roesch, E Roesch

British Journal of Pharmacology

|July 1, 1976

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial.

ESMO open·2025

Qualitative Descriptions of Developer Changes or Consistency Over Time.

The chronicle of mentoring & coaching·2025

Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.

European journal of cancer (Oxford, England : 1990)·2023

Management of partial and non-responding cutaneous squamous cell carcinoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

The predictive and prognostic significance of cell-free DNA concentration in melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

See all related articles